BioVescent is advancing pharmaceutical and therapeutic care with its patented ketamine, psychedelic, and alternative medicine formulations. Our exclusively licensed proprietary technology converts oils and low soluble active pharmaceutical ingredients (APIs) into enhanced, ultra-bioavailable powder. BioVescent powder particles are microencapsulated and enteric coated to release at target pH-levels, delivering up to 95% of a drug’s active ingredient for optimal absorption into the body. Our flagship product is the world's first pH-target released, dry powder, orally inhalable ketamine, ensuring up to 65% bioavailability and peak onset of four minutes. Additional BioVescent psychedelic formulations include psilocybin, LSD, and MDMA. Our cannabis formulations include THC, THC-V, CBD, CBG, CBN, and other minor cannabinoids. BioVescent powder can be used for therapeutic and recreational purposes, as direct inhalables, ingestible VCap capsules, or as water soluble manufacturing ingredients. 𝗕𝗶𝗼𝗩𝗲𝘀𝗰𝗲𝗻𝘁: 𝗧𝗵𝗲 𝗗𝗼𝘀𝗲 𝗧𝗵𝗮𝘁 𝗗𝗼𝗲𝘀 𝗜𝘁.